Northrop Grumman (NOC) was awarded a $167.93M modification to a firm-fixed-price, indefinite-delivery/indefinite-quantity contract. This modification exercises option contract line items, or CLIN, 1001 and 2001 and increases the contract ceiling for the production of 50,000 FMU-139D/B Bomb Tactical Electronic Fuze systems, 25,000 for CLIN 1001, and 25,000 for CLIN 2001, in support of the Joint Direct Attack Mission family of weapons for the Navy, Air Force, and Foreign Military Sales customers. Work is expected to be completed in December 2029. No funds will be obligated at the time of award, funds will be obligated on individual orders as they are issued. This contract was not competed. Naval Air Systems Command is the contracting activity.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman price target raised to $550 from $500 at Barclays
- Jefferies aerospace & defense analysts hold analyst/industry conference call
- Northrop Grumman price target raised to $600 from $565 at BTIG
- Northrop Grumman price target raised to $605 from $592 at Morgan Stanley
- Northrop Grumman price target raised to $540 from $500 at RBC Capital